Figure 3.
KDR copy number gain (CNG) associated with outcome in NSCLC patients treated with adjuvant chemotherapy. Kaplan-Meier curve for overall survival (OS) and recurrence-free survival (RFS) by KDR CNG in NSCLC patients and two subgroups of platinum adjuvant therapy and without adjuvant therapy (E, event; N, total number of cases).